Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.

Who May Be Eligible (Plain English)

Who May Qualify: - Age ≥ 18 years; - Brazilian resident; - Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment. Who Should NOT Join This Trial: - No availability to participate in remote research appointments; - Communication difficulty (aphasia, important hearing loss, non-portuguese speaker, severe dementia) - Refuse to provide willing to sign a consent form Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age ≥ 18 years; * Brazilian resident; * Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment. Exclusion Criteria: * No availability to participate in remote research appointments; * Communication difficulty (aphasia, important hearing loss, non-portuguese speaker, severe dementia) * Refuse to provide informed consent

Treatments Being Tested

OTHER

Multiple exposures

Exposures variables (observational study): age, gender, education, comorbidities, vaccination status, severity of the acute episode of COVID-19, treatments used for acute COVID-19.

Locations (1)

Inova Medical
Cachoeirinha, Rio Grande do Sul, Brazil